Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Ghrelin receptor agonist for treatment of cachexia

Ghrelin receptor agonist for treatment of cachexia

US Patent 10975070 · Granted Apr 13, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Adsorbing material for soluble tumor necrosis factor receptor2024
Selective EP4 receptor antagonistic substance for treatment of cancer2023
Material for removing activated leukocyte-activated platelet complex2023
Sodium hypochlorite pentahydrate crystals and method for producing same2022
Carrier for adsorbing organic matter2021
Method for producing rare fatty acid using novel enzyme, and novel rare fatty ac2021
Uses of benzimidazole derivative for nocturnal acid breakthrough2021
Uses of benzimidazole derivative for nocturnal acid breakthrough2021
Metabolism-improving agent comprising rare fatty acid2021
Selective EP4 receptor antagonistic substance for treatment of cancer2021
Material for removing activated leukocyte-activated platelet complex2021
Selective EP4 receptor antagonistic substance for treatment of cancer2020